Autoantibody Profiling in Prostvac and Ipilimumab Treated Prostate Cancer Patients Reveals Potential Biomarkers of Immune-Related Adverse Events-MedSci.cn

Autoantibody Profiling in Prostvac and Ipilimumab Treated Prostate Cancer Patients Reveals Potential Biomarkers of Immune-Related Adverse Events

Budde, P; Marte, J; Zucht, HD; Bhandari, S; Tuschen, M; Schulz-Knappe, P; Gulley, J; Heery, C; Madan, R; Schlom, J

ARTHRITIS & RHEUMATOLOGY, 2017; 69 ( ):

科室
- - 订阅+
  - 更多科室
工具
服务